In addition, we have also tested the mRNA expression of AMPKα1 and AMPKα2 in 24 CRC patients’ tumor samples, in which AMPKα1 showed much higher expression than AMPKα2 in all tumor samples (Fig. 1c). This evidence concerns the gene PRKAA2 and colorectal carcinoma.